Access Vascular, Inc HydroMID 4Fr Single Lumen Maximal Barrier Kit-indicated for short term access (<30days) to the peripheral venous access system for intravenous therapy Product Number: 80004004 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
HydroMID 4Fr Single Lumen Maximal Barrier Kit-indicated for short term access (<30days) to the peripheral venous access system for intravenous therapy Product Number: 80004004
Brand
Access Vascular, Inc
Lot Codes / Batch Numbers
UDI-DI: (01)00850030354020 Lot Numbers: 11424032, 11432076
Products Sold
UDI-DI: (01)00850030354020 Lot Numbers: 11424032, 11432076
Access Vascular, Inc is recalling HydroMID 4Fr Single Lumen Maximal Barrier Kit-indicated for short term access (<30days) to the per due to Label with the incorrect component listed on the inner kit Tyvek header bag. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Label with the incorrect component listed on the inner kit Tyvek header bag
Recommended Action
Per FDA guidance
Access Vascular issued Urgent Medical Device Correction-HydroMID Labeling on 12/22/22. Letter states reason for recall, health risk and action to take: Product that has already been used: No action required. There is no patient safety risk has been identified. - Product that has not been used: The kit labeling identified components which are not included in the kit, however there is no immediate patient safety risk. However, please refrain from using these kits as additional kit components may be required may cause an inconvenient in completing the procedure. AVI will provide a replacement label with the correct contents or replace the product. Please forward this notice in the event the affected product was further distributed. We will contact you to identify the number of kits that are currently in your inventory and determine the appropriate correction with your input, in a timely manner. If you have any questions about this communication, please contact us at 781-538-6594.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026